Need help choosing the right code?
Ask CasePilot about procedures, modifiers, bundling, and coding guidance.
Try CasePilot© Copyright 2026 American Medical Association. All rights reserved.
Intracutaneous (intradermal) tests are diagnostic procedures utilized to assess allergic reactions to specific airborne allergens. During this procedure, allergenic extracts are administered just beneath the skin's surface, allowing for the observation of immediate type reactions. The tests are designed to provoke a response that can be evaluated for signs of allergy, such as redness, swelling, or inflammation at the injection sites. A qualified healthcare professional, typically a physician, monitors these reactions closely. Following the testing, the results are meticulously interpreted, and a comprehensive written report is generated. This report details the number of allergens tested, the specific allergenic extracts utilized, and the presence, absence, or degree of any allergic reactions observed. For coding purposes, the appropriate CPT® code to use for these intracutaneous allergy tests is 95027.
© Copyright 2026 Coding Ahead. All rights reserved.
Intracutaneous (intradermal) tests are indicated for the evaluation of immediate type allergic reactions to airborne allergens. These tests are typically performed when a patient presents with symptoms suggestive of an allergy, such as respiratory issues, skin reactions, or other allergic manifestations. The procedure is essential for identifying specific allergens that may be contributing to the patient's symptoms, allowing for targeted management and treatment.
The procedure for conducting intracutaneous (intradermal) tests involves several key steps to ensure accurate results and patient safety. Initially, the healthcare provider prepares the patient by reviewing their medical history and any previous allergic reactions. The skin is then cleansed to minimize the risk of infection. Following this, one or more allergenic extracts are carefully injected just beneath the skin's surface using a fine needle. The injection sites are strategically chosen, often on the forearm, to allow for easy observation. After the injections, the healthcare professional monitors the sites for any immediate reactions, which typically occur within a short time frame. The reactions are assessed for signs such as redness, swelling, or other indicators of an allergic response. Finally, the results are interpreted, and a detailed report is generated, specifying the number of tests conducted, the specific allergenic extracts used, and the degree of any reactions observed.
After the intracutaneous tests are completed, patients are typically advised to remain in the healthcare setting for a brief period to ensure that any immediate reactions can be monitored. Post-procedure care may include instructions on how to care for the injection sites, such as keeping them clean and avoiding scratching. Patients may also be informed about potential delayed reactions that could occur after leaving the facility. The healthcare provider will discuss the results of the tests with the patient, including any identified allergens and recommendations for further management or avoidance strategies. Follow-up appointments may be scheduled to discuss treatment options based on the test results.
| Short Descr | IQ TSTS SEQL&INCRL AIRBORNE | Medium Descr | IQ TSTS SEQL&INCRL W/ALLERGENIC XTRCS AIRBORNE | Long Descr | Intracutaneous (intradermal) tests, sequential and incremental, with allergenic extracts for airborne allergens, immediate type reaction, including test interpretation and report, specify number of tests | Status Code | Active Code | Global Days | XXX - Global Concept Does Not Apply | PC/TC Indicator (26, TC) | 0 - Physician Service Code | Multiple Procedures (51) | 0 - No payment adjustment rules for multiple procedures apply. | Bilateral Surgery (50) | 0 - 150% payment adjustment for bilateral procedures does NOT apply. | Physician Supervisions | 02 - Procedure must be performed under the direct supervision of a physician. | Assistant Surgeon (80, 82) | 0 - Payment restriction for assistants at surgery applies to this procedure... | Co-Surgeons (62) | 0 - Co-surgeons not permitted for this procedure. | Team Surgery (66) | 0 - Team surgeons not permitted for this procedure. | Diagnostic Imaging Family | 99 - Concept Does Not Apply | APC Status Indicator | STV-Packaged Codes | Type of Service (TOS) | 1 - Medical Care | Berenson-Eggers TOS (BETOS) | T2D - Other tests - other | MUE | 90 | CCS Clinical Classification | 173 - Other diagnostic procedures on skin and subcutaneous tissue |
| 59 | Distinct procedural service: under certain circumstances, it may be necessary to indicate that a procedure or service was distinct or independent from other non-e/m services performed on the same day. modifier 59 is used to identify procedures/services, other than e/m services, that are not normally reported together, but are appropriate under the circumstances. documentation must support a different session, different procedure or surgery, different site or organ system, separate incision/excision, separate lesion, or separate injury (or area of injury in extensive injuries) not ordinarily encountered or performed on the same day by the same individual. however, when another already established modifier is appropriate it should be used rather than modifier 59. only if no more descriptive modifier is available, and the use of modifier 59 best explains the circumstances, should modifier 59 be used. note: modifier 59 should not be appended to an e/m service. to report a separate and distinct e/m service with a non-e/m service performed on the same date, see modifier 25. | 76 | Repeat procedure or service by same physician or other qualified health care professional: it may be necessary to indicate that a procedure or service was repeated by the same physician or other qualified health care professional subsequent to the original procedure or service. this circumstance may be reported by adding modifier 76 to the repeated procedure or service. note: this modifier should not be appended to an e/m service. | XU | Unusual non-overlapping service, the use of a service that is distinct because it does not overlap usual components of the main service | GC | This service has been performed in part by a resident under the direction of a teaching physician | GA | Waiver of liability statement issued as required by payer policy, individual case | GY | Item or service statutorily excluded, does not meet the definition of any medicare benefit or, for non-medicare insurers, is not a contract benefit | XS | Separate structure, a service that is distinct because it was performed on a separate organ/structure | GV | Attending physician not employed or paid under arrangement by the patient's hospice provider |
|
Date
|
Action
|
Notes
|
|---|---|---|
| 2025-01-01 | Changed | Short and Medium Descriptions changed. |
| 2013-01-01 | Changed | Description Changed |
| 2008-01-01 | Changed | Code description changed. |
| 2003-01-01 | Changed | Code description changed. |
| Pre-1990 | Added | Code added. |
Get instant expert-level medical coding assistance.